Dow Jones

52 305,24

-0,03%

Germany 40

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Grifols SA (GRFS)

7,085

0,005

(0,07%)

Fermé 02 Juillet 10:00PM

7,085

0,00

(0,00%)

Après les heures de négociation: 1:55AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.

The new fibrinogen concentrate, approved in the U.S. for acute bleeding episodes in pediatric and adult...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease

Chronos‑PD shows that biological changes associated with Parkinson’s disease (PD) can emerge up to 12 years...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Ensign Energy Services

XE

SPFA

State Street SPDR Bloomb...

TG

4RUP

WisdomTree Commodity Sec...

Ci Global Leaders Corpor...

TSXV

CMC

Cielo Waste Solutions

Ab Short Duration Income...

Australian Governance an...

Converge Technology Solu...

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Grifols SA (GRFS)

Outils de qualité professionnelle, pour des investisseurs individuels.

Grifols SA (GRFS) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Grifols SA (GRFS)

Outils de qualité professionnelle, pour des investisseurs individuels.

Grifols SA (GRFS) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités